Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Confronto tra PPV e VTI del LVOT durante l'innalzamento passivo delle gambe per prevedere la responsività ai fluidi

3 novembre 2026 aggiornato da: Ahmet Salih Tüzen, MD, Izmir Katip Celebi University

Confronto tra la Variazione della Pressione di Pulsazione e le Variazioni della Gittata Cardiaca Basate sul VTI del LVOT Durante la Manovra di Sollevamento Passivo degli Arti Inferiori nella Predizione della Risposta ai Fluidi in Pazienti Critici Ventilati Meccanicamente: Uno Studio Osservazionale Prospettico

Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.

The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.

The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.

Panoramica dello studio

Descrizione dettagliata

This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.

In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.

In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.

Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:

  • Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
  • Non-fluid responsive: Patients showing <10% change in LVOT VTI-based CO following PLR

After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.

The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.

The recorded data will include:

  • Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
  • Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
  • Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database

Informed consent will be obtained from all participating patients or their legally authorized representatives.

Tipo di studio

Osservativo

Iscrizione (Stimato)

48

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Ahmet Salih Tüzen, M.D.
  • Numero di telefono: +90 535 391 55 77
  • Email: astuzen@icloud.com

Backup dei contatti dello studio

Luoghi di studio

      • Izmir, Turchia (Türkiye)
        • Reclutamento
        • Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population consists of adult critically ill patients admitted to the Intensive Care Unit (ICU) who are receiving mechanical ventilation support. Eligible participants are those identified by the intensive care team as having a suspected intravascular fluid deficit, for whom a fluid responsiveness assessment is clinically indicated. The cohort specifically targets patients undergoing the Passive Leg Raising (PLR) maneuver as part of routine standard practice, where invasive arterial monitoring is available to record Pulse Pressure Variation (PPV).

Descrizione

Inclusion Criteria:

  1. Adult patients aged ≥18 years
  2. Patients admitted to the intensive care unit receiving mechanical ventilation
  3. Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
  4. Patients in sinus rhythm
  5. Presence of invasive arterial blood pressure monitoring
  6. Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
  7. Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
  8. Hemodynamically stable enough to allow measurement

Exclusion Criteria:

  1. Patients under 18 years of age
  2. Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
  3. Severe right ventricular dysfunction or significant tricuspid regurgitation
  4. Advanced aortic valve disease (severe stenosis or severe regurgitation)
  5. Patients with significant spontaneous breathing effort
  6. Patients receiving lung-protective low tidal volume ventilation strategy (<8 mL/kg) due to ARDS
  7. Inadequate echocardiographic window for LVOT VTI assessment
  8. Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
  9. Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Fluid Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline.

Fluid Non-Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of < 10% from baseline.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Pulse Pressure Variation (Delta PPV)
Lasso di tempo: Baseline (T0) and between 60 seconds after the PLR maneuver.

Pulse Pressure Variation (PPV) is recorded via invasive arterial monitoring at baseline (T0, semi-sitting) and during the Passive Leg Raising maneuver (T1).

Baseline (T0) and between 60 seconds after the PLR maneuver.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Percentage Change in Cardiac Output (Delta CO)
Lasso di tempo: Baseline (T0) and between 60 seconds after the PLR maneuver.

Cardiac Output (CO) is calculated using the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) and the LVOT diameter measured via transthoracic echocardiography.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Correlation between Delta PPV and Delta CO
Lasso di tempo: Baseline (T0) and between 60 seconds after the PLR maneuver.

Correlation Coefficient (r) between PPV Change and Cardiac Output Change

Baseline (T0) and between 60 seconds after the PLR maneuver.
Hemodynamic Parameter Changes (MAP, HR)
Lasso di tempo: Baseline (T0) and between 60 seconds after the PLR maneuver.

Measurement of changes in mean arterial pressure and heart rate before and after PLR and comparison between groups.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Diagnostic Accuracy (ROC-AUC, Sensitivity, Specificity, Cut-off)
Lasso di tempo: Baseline (T0) and between 60 seconds after the PLR maneuver.

Evaluation of diagnostic performance of ΔPPV and ΔCO using receiver operating characteristic (ROC) analysis, including AUC, optimal cut-off value, sensitivity, and specificity for predicting fluid responsiveness.

Baseline (T0) and between 60 seconds after the PLR maneuver.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Murat Aksun, Izmir Katip Celebi University Atatürk Training and Research Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 gennaio 2026

Completamento primario (Stimato)

1 gennaio 2027

Completamento dello studio (Stimato)

1 giugno 2027

Date di iscrizione allo studio

Primo inviato

13 dicembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

13 dicembre 2025

Primo Inserito (Effettivo)

26 dicembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

4 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

All data necessary to support the study protocol, including de-identified individual participant data (IPD) related to study protocol, and primary and secondary outcome measures, will be made available upon reasonable request from qualified researchers for academic purposes, in accordance with institutional and ethical guidelines.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi